Europa Biosite has announced a new strategic distribution partnership with Quantoom Biosciences, a leading manufacturer of innovative mRNA technologies supporting next generation vaccines and therapeutics. The agreement provides access to Quantoom’s pioneering research RNA production solutions for scientists across Europe.
Under the partnership, Europa Biosite will distribute Quantoom’s Ntensify® mano and Ntensify® micro technology, designed for rapid and qualitative RNA production in research settings. The collaboration is expected to broaden to include Ncapsulate® LNP formulation kits as these technologies become available to the research market.
Europa Biosite is recognized for building high-quality supplier relationships and delivering advanced reagents and technologies to academic, biotech, and pharmaceutical laboratories through its pan-European distribution network. The addition of Quantoom’s RNA production portfolio strengthens Europa Biosite’s offering in the rapidly expanding RNA research field.
José Castillo, CEO of Quantoom Biosciences commented “Europa Biosite has built an impressive reputation for connecting innovative technologies with leading research laboratories across Europe”. He added “By joining forces, we make high-quality RNA production and formulation tools more accessible, helping researchers accelerate the development of next-generation RNA applications.”
Partner with Europa Biosite
Europa Biosite partners with life science suppliers who share our values on quality, innovation and service.
If you are looking for a leading European and US distributor partner, we want to hear from you.